Long term vagal stimulation in patients with advanced heart failure First experience in man
about
Non-pharmacological modulation of the autonomic tone to treat heart failureCholinergic activity as a new target in diseases of the heartLow-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillationDonepezil, anti-Alzheimer's disease drug, prevents cardiac rupture during acute phase of myocardial infarction in miceTranscutaneous vagus nerve stimulation: retrospective assessment of cardiac safety in a pilot study.Vagus nerve stimulation: An evolving adjunctive treatment for cardiac disease.Role of neural modulation in the pathophysiology of atrial fibrillation.The vagus nerve and the inflammatory reflex--linking immunity and metabolism.Sympathetic nerve fibers in human cervical and thoracic vagus nervesLow-level right vagal stimulation: anticholinergic and antiadrenergic effects.Electrophysiological effects of right and left vagal nerve stimulation on the ventricular myocardium.Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention.Optimizing the parameters of vagus nerve stimulation by uniform design in rats with acute myocardial infarction.A non-neuronal cardiac cholinergic system plays a protective role in myocardium salvage during ischemic insultsRationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trialVagal nerve stimulation therapy: what is being stimulated?Short‑term vagal nerve stimulation improves left ventricular function following chronic heart failure in rats.Autonomic Regulation Therapy in Heart FailureAcetylcholine ameliorates endoplasmic reticulum stress in endothelial cells after hypoxia/reoxygenation via M3 AChR-AMPK signalingNovel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases.Protection against ischemia-induced oxidative stress conferred by vagal stimulation in the rat heart: involvement of the AMPK-PKC pathwayModulation of heart rate by temporally patterned vagus nerve stimulation in the anesthetized dogProtection against ventricular fibrillation via cholinergic receptor stimulation and the generation of nitric oxide.Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1α-related defense mechanisms.Association of heart rate variability and inflammatory response in patients with cardiovascular diseases: current strengths and limitations.Basis for sudden cardiac death prediction by T-wave alternans from an integrative physiology perspectiveHeart rate, autonomic markers, and cardiac mortality.Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGA.Heart failure-induced changes of voltage-gated Ca2+ channels and cell excitability in rat cardiac postganglionic neurons.Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training.Review article: the new concept of interventional heart failure therapy--part 1: electrical therapy, treatment of CAD, fluid removal, and ventricular support.Arrhythmias and vagus nerve stimulation.Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.Pharmacologic modulation of parasympathetic activity in heart failure.Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.The vagus nerve and autonomic imbalance in heart failure: past, present, and future.Vagal nerve modulation: a promising new therapeutic approach for cardiovascular diseases.Nicotinic acetylcholine receptor α7 subunit: a novel therapeutic target for cardiovascular diseases.
P2860
Q26822899-420158E8-367F-4C78-84BC-EA09FBE57840Q27004543-33C0C5B2-38AF-4FD7-9B66-080D71BBE14FQ28258399-1F9042A7-A025-4657-81F0-5AEDD4827845Q28478916-EAAC69B4-CCB5-44E2-8B55-3D386E01515BQ30464737-EFF5750C-E3DA-4AFC-8DC4-86C209DB6E4EQ33167779-E91C3D02-537D-415D-807B-810B7F3EC745Q33833632-F65882EB-7058-4CE6-8A44-10096F053296Q33847366-63AA30FA-3C37-47BB-84E7-7B2ED36F7741Q33940757-0BE4020E-E9E6-4806-B8F5-2797F3D3A032Q34177969-F42F340A-57D5-4670-91C5-551D4F3592C6Q34296743-2FC21351-F001-4F18-A06B-16F0FE97D6DCQ34469254-F1DF1FFA-5079-40FA-8907-D1074457F854Q34493636-4C0B9559-9E3D-4002-96E3-0E70280F6E34Q34500704-A4F6B2C5-86A7-47B5-98BA-BCEDD7ABDCFCQ34891236-0E86B96B-D029-4367-885D-997BD1D0FB34Q35083803-D7A743E9-86D7-499D-97EB-867CAE378CC9Q35494572-A04080CC-5668-41C0-AEB3-9CAFDD29ACB7Q35728652-A5F272EA-622A-4B03-94CF-BD577527DC77Q36165288-8652ADD6-53D3-4307-A309-B1D9FE9DFC21Q36184518-A1F92D43-0B6D-4BD8-BE31-78B9B3E89186Q36342131-429A6186-F491-4C96-B831-DA622945B59EQ36432460-5253EF63-4BC3-42E9-8124-623ADEBC43B2Q36597681-36BAA5E1-AD72-488E-8ADB-8E00C65239AEQ36693688-B9B45B03-2075-43CD-87D3-48813B93A624Q36701807-FA8D8BCE-329C-4FAC-8AB4-1FD10F391AE2Q36997812-E90084C1-548C-4F4D-ABCB-6BED74FD8455Q37167055-2643A56A-10A9-4EBB-A4AC-7D00061E513FQ37418558-D0F1A0F6-9483-4BD7-A6E6-33BF04317766Q37494358-D7AD5D35-6069-4DE9-96C4-CCF42DB99442Q37495281-319450B0-34F8-4BE8-A0C9-9B26FFE5857FQ37575319-BD726530-759D-4961-8031-66D4061008BCQ37580600-1A38369E-8E62-43B6-B680-52B06C9DC452Q37740801-D5F52C3F-79E1-4FB4-A9A2-CC6A88768E33Q37766114-82BD5FF6-B8A8-4D34-8356-935F982FE44FQ37775559-DD10FD0A-5246-4FC5-98BD-92B840245232Q37798181-A1B5D23E-1579-4F23-993F-4CE2661F3852Q37821801-3EEDB369-4C74-49D0-9FC9-ADDDA3650AFDQ37824616-3D97313F-00FC-4036-875D-B6F2BB7E7232Q37955271-54F56ABF-193E-4A0C-A7CC-9011C3A45F3AQ37998368-B2CE6297-32F4-4A2A-B8D5-F0A0D0624E74
P2860
Long term vagal stimulation in patients with advanced heart failure First experience in man
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Long term vagal stimulation in ...... ailure First experience in man
@en
Long term vagal stimulation in ...... ailure First experience in man
@nl
type
label
Long term vagal stimulation in ...... ailure First experience in man
@en
Long term vagal stimulation in ...... ailure First experience in man
@nl
prefLabel
Long term vagal stimulation in ...... ailure First experience in man
@en
Long term vagal stimulation in ...... ailure First experience in man
@nl
P2093
P50
P1476
Long term vagal stimulation in ...... ailure First experience in man
@en
P2093
Antonio Sanzo
Attilio Odero
Carlo Campana
Claudia Raineri
Gaetano M. De Ferrari
Maurizio Landolina
Nina Ajmone-Marsan
Roberto Rordorf
P304
P356
10.1016/J.EJHEART.2008.07.016
P577
2008-09-01T00:00:00Z